- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06854731
Preventing Falls in Older Adults With Cognitive Frailty (ACTIVE)
ACTIVE: Adding Life to Years in Cognitive Frailty by Preventing Falls
The Problem: The proposed trial will address the problem of how to effectively prevent subsequent falls in community-dwelling cognitively frail older adults with a history of falls.
Primary Question: In community-dwelling older adults with cognitive frailty and a history of falls, can a home-based exercise program with behavioural change techniques significantly reduce falls vs. health education (i.e., control; CON)?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: Falls are a significant cause of functional decline and often a sentinel event. Older adults with cognitive frailty - those with concurrent physical frailty and mild cognitive impairment - are at particular risk for falls. Notably, falls can cause a sudden and severe change in their health state from one of independence to one of dependence. Thus, effective falls prevention strategies need to be identified for older adults with cognitive frailty.
The Otago Exercise Program (OEP) - a physical therapist (PT) delivered home-based exercise program - is an evidence-based falls prevention program for community-dwelling older adults. Our pilot data show the OEP vs. usually care significantly reduced subsequent falls in 192 community-dwelling older adults with cognitive frailty and a history of falls; the incident rate ratio was 0.64 (95% CI, 0.43-0.98; P = .042). These preliminary findings need to be confirmed in a rigorously designed RCT powered for falls in older adults with cognitive frailty; none exist to date.
We also observed lower OEP adherence among older adults with cognitive frailty vs. those without cognitive frailty. Thus, strategies to support adherence must be considered in RCTs of exercise to prevent falls in this high-risk population. Evidence-based strategies include health coaching.
Thus, we propose a 12-month multi-site randomized controlled trial (RCT) in older adults with cognitive frailty and a history of falls to assess the efficacy of the OEP combined with health coaching (i.e., OEP+) to prevent falls.
Primary Question: In community-dwelling older adults with cognitive frailty and a history of falls, can the OEP+ significantly reduce falls vs. health education (i.e., control; CON)?
Secondary Questions: 1) What are additional benefits of the OEP+ vs. CON? 2) Do the benefits of OEP+ persist 6 months post cessation? 3) Can the OEP+ reduce falls or improve quality of life at similar or lower costs vs. CON?
Methods: A 12-month assessor-blinded, multi-site RCT, with a 6-month follow-up, in older adults, with cognitive frailty - defined by a Short Physical Performance Battery score <= 9/12 and a Montreal Cognitive Assessment score between 18-25/30 - and a history of falls. Participants will be randomized to either: a) OEP+ or b) CON. The OEP+ intervention will include Brief Action Planning-based health coaching. The CON group will include monthly interactive education sessions via Zoom. Measurement will occur at baseline, 6, 12, and 18 months, with falls tracked daily.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Teresa Liu-Ambrose, PhD
- Phone Number: 6046178047
- Email: teresa.ambrose@ubc.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z1M9
- Recruiting
- Centre for Aging SMART at VCH, University of BC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
We will include individuals who meet the following criteria: 1) aged between 65 and 89 years; 2) live in Greater Vancouver, British Columbia; 3) are community-dwelling (i.e., not residing in a nursing home or extended care unit); 4) experienced a non-syncopal fall in the prior 12 months; 5) scored ≤ 9/12 on the SPPB; 6) have subjective cognitive impairment based on interview; 7) scored 18-25/30 on the MoCA [62,64]; 8) are able to walk with or without a gait aid; 9) scored ≥ 6/8 on Lawton and Brody Instrumental Activities of Daily Living Scale (IADL) [65]; 10) are able to safely engage in exercise as indicated by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) [66]; and 11) are able to understand, speak, and read English with sufficient proficiency to complete the assessments.
*The age maximum of 89 was set due to the increased risk of significant adverse health outcomes cognitively frail older adults face. As this population has an increased risk of falls, functional disability with loss of independence, hospitalization, and death, setting an age maximum aims to increase the likelihood that participants will be able to complete the 18-month study without interruptions due to health complications. This age limit has been reviewed and approved by CIHR.
Exclusion Criteria:
We will exclude individuals who: 1) have been diagnosed with dementia, a neurodegenerative disease, or stroke; 2) report engaging in strength and balance training exercises ≥ 2 times per week in the prior 3 months; 3) have severe depression based on a score of ≥ 11/15 on the GDS.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Educational Control
All active control participants will be invited to join monthly interactive education sessions via Zoom or in-person.
|
All active comparator participants will be invited to join monthly interactive social and education sessions via Zoom or in-person (hybrid delivery).
|
|
Experimental: Otago Exercise Program (OEP) Plus
The OEP+ intervention integrates the OEP with health coaching by a physical therapist or kinesiologist.
The OEP is an individualized home-based balance and strength exercise training program delivered by a PT or kinesiologist coach over 5 home visits and 6 phone check-ins
|
The OEP+ intervention integrates the OEP with health coaching by a physical therapists or kinesiologist.
The OEP is an individualized home-based balance and strength exercise training program delivered by a PT or kinesiologist coach over 5 home visits.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Falls
Time Frame: Daily tracking over 12 months
|
The number of self-reported falls during the 12-month intervention period (i.e., rate of falls).
|
Daily tracking over 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Physical Performance Battery
Time Frame: Baseline, 6 months, 12 months, 18 months
|
A physical performance battery out of 12 points (max.
performance).
|
Baseline, 6 months, 12 months, 18 months
|
|
Montreal Cognitive Assessment
Time Frame: Baseline, 6 months, 12 months, 18 months
|
A test that covers multiple cognitive domains.
Often used to screen for mild cognitive impairment.
|
Baseline, 6 months, 12 months, 18 months
|
|
Falls during followup period
Time Frame: Daily tracking from 12 months (trial completion) to end of 6-month followup (18 months)
|
The number of self-reported falls during the 6-month ifollowup period (i.e., rate of falls).
|
Daily tracking from 12 months (trial completion) to end of 6-month followup (18 months)
|
|
Memory
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Memory measured by the Rey Auditory Verbal Learning Test
|
Baseline, 6 months, 12 months, 18 months
|
|
Gait Speed
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Walking speed in m/s measured over 4 meters (part of the Short Physical Performance Battery)
|
Baseline, 6 months, 12 months, 18 months
|
|
Muscle Strength
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Dominant quadriceps strength and dominant hand grip strength.
|
Baseline, 6 months, 12 months, 18 months
|
|
Community Mobility
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Life Space Questionnaire to measure community mobility
|
Baseline, 6 months, 12 months, 18 months
|
|
Functional Mobility
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Timed Up and Go Test to measure functional mobility
|
Baseline, 6 months, 12 months, 18 months
|
|
Fear of Falling
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Fear of falling as assessed by the Iconographical Falls Efficacy Scale (Icon-FES).
|
Baseline, 6 months, 12 months, 18 months
|
|
Health Resource Utilization (HRU)
Time Frame: Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
|
Cost data will be collected every 3 months using the HRU questionnaire
|
Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
|
|
Sleep Quality (Objective) - Optional
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Sleep quality parameters will be measured using ActiGraph
|
Baseline, 6 months, 12 months, 18 months
|
|
Brain Function - Optional
Time Frame: Baseline, 6 months, 12 months
|
Brain function will be measured using functional near-infrared spectroscopy
|
Baseline, 6 months, 12 months
|
|
NIH Cognitive Toolbox
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Cognitive function measured using the NIH Cognitive Toolbox: Dimensional Change Card Sort Test and Flanker Inhibitory Control and Attention Test
|
Baseline, 6 months, 12 months, 18 months
|
|
Processing speed
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Processing speed measured by Digit Symbol Substitution Test
|
Baseline, 6 months, 12 months, 18 months
|
|
Fatigue
Time Frame: Baseline, 6 months, 12 months, 18 months
|
The 9-item Fatigue Severity Scale will be used to assess how fatigue interferes with certain activities and its severity.
|
Baseline, 6 months, 12 months, 18 months
|
|
Quality of Life
Time Frame: Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
|
The EuroQol EQ-5 Domain (5D)-5 Level (5L) (EQ-5D-5L) and the EuroQol Visual Analogue Scale (EQ-VAS) will assess quality of life
|
Baseline, 3 months, 6 months, 9 months, 12 months, 18 months
|
|
Physical Frailty
Time Frame: Baseline, 6 months, 12 months, 18 months
|
The Short Physical Performance Battery (physical performance battery out of 12 points (max.
performance) and the Fried Frailty Phenotype (scores range from 0-5 where 0 is characterized as non-frail, 1-2 as pre-frail and >=3 as frail)
|
Baseline, 6 months, 12 months, 18 months
|
|
Physical Activity
Time Frame: Baseline, 6 months, 12 months, 18 months
|
The Physical Activity Scale for the Elderly (PASE) will be used to measure physical activity levels.
PASE is a 12-item scale.
|
Baseline, 6 months, 12 months, 18 months
|
|
Mood
Time Frame: Baseline, 6 months, 12 months, 18 months
|
15-item Geriatric Depression Scale (GDS) will be used to assess depressive symptoms.
GDS score of >=11/15 is suggestive of severe depression
|
Baseline, 6 months, 12 months, 18 months
|
|
Fall Risk
Time Frame: Baseline, 6 months, 12 months, 18 months
|
Fall risk is assessed by the Physiological Profile Assessment (PPA).
A PPA z-score of 0-1 is indicative of mild fall risk, 1-2 indicates moderate risk, 2-3 indicates high risk, and > 3 indicates marked risk
|
Baseline, 6 months, 12 months, 18 months
|
|
Frailty Index
Time Frame: Baseline, 6 months, 12 months, 18 months
|
A frailty index will be calculated based on an accumulation of deficits across multiple domains and constructed using our primary and secondary outcome measures.
|
Baseline, 6 months, 12 months, 18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Teresa Liu-Ambrose, PhD, University of British Columbia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H23-01584
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.